Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1427048

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1427048

Outsourced Clinical Trials & Formulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 213 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

The global outsourced clinical trials & formulation market continues its upward trajectory, poised to achieve a market valuation of US$ 23 billion by the end of 2031, growing at a robust CAGR of 7.0%. This surge is attributed to the escalating reliance of pharmaceutical companies on outsourcing due to various factors such as constraints in manufacturing facilities, dearth of advanced technologies, and increased demand for backup manufacturing.

Opportunities for Manufacturers:

Manufacturers in the outsourced clinical trials & formulation market are presented with abundant opportunities, particularly through collaboration with pharmaceutical and biotech companies. Strategic alliances and partnerships enable manufacturers to enhance their market size and strengthen their product portfolios. Moreover, technological advancements in formulations, manufacturing, and testing further augment these opportunities, ensuring sustainable growth.

Challenges and Restraints:

Despite the promising outlook, the market faces challenges, primarily stemming from stringent regulations imposed by regulatory bodies, particularly in developed nations. Smaller contract development and manufacturing organizations lacking cutting-edge equipment may encounter process errors, quality issues, and pricing challenges. Additionally, intense competition among market players necessitates strategic maneuvers such as expansions, collaborations, and acquisitions to maintain dominance, thereby restraining demand growth.

Country-wise Insights:

  • Leading Market in the U.S.: The United States dominates the North American market, driven by high API manufacturing rates, superior healthcare accessibility, and robust clinical research infrastructure. Government incentive programs further stimulate demand, fostering continuous revenue growth.
  • Rising Demand in Germany: Germany boasts a stellar record in clinical research, supported by high population density and an extensive network of health facilities. These factors contribute to the country's substantial market share in Europe, fueling demand for outsourced clinical trials & formulations.
  • Emerging Prominence in China: China emerges as a prominent market in East Asia, propelled by rapidly developing healthcare infrastructure and cost-effective labor. The country's focus on API production and bulk drug manufacturing enhances its appeal as an outsourcing destination, attracting significant investments from industry players.
  • India's API Production Leadership: India solidifies its position as a global leader in API production, leveraging its robust pharmaceutical sector to drive growth in the outsourced clinical trials & formulation market. Expansion initiatives by key players present lucrative opportunities for market entrants in the Indian landscape.

Market Consolidation and Key Players:

The market witnesses intense competition, prompting key players to prioritize full-service offerings and strategic collaborations to expand market share. Notable companies such as Thermo Fisher Scientific Inc., Piramal Pharma Solutions, and Lonza Group lead the industry with their comprehensive solutions and innovative approaches.

Key Companies Profiled:

  • Thermo Fisher Scientific Inc. (Patheon)
  • Piramal Pharma Solutions
  • BioXcellence (Boehringer Ingelheim International GmbH)
  • Siegfried Holding AG
  • Evotec A.G.
  • Ascendia Pharmaceuticals
  • Experic Services
  • Quotient Sciences
  • Velesco Pharmaceutical Services, Inc.
  • Elements Group (Avomeen)
  • VxP Pharma
  • Adare Pharmaceuticals, Inc.
  • KP Pharmaceutical Technology Inc.
  • Enteris Biopharma, Inc.
  • Aenova Holding GmbH
  • Ardena Holding NV
  • Pharmaceutics International, Inc.
  • Alcami Corporation, Inc.
  • NextPharma Technologies
  • Corden Pharma International GmbH
  • Corerx, Inc.
  • Recipharm AB
  • Pace Analytical Services, LLC
  • Almac Group, Inc.
  • Cambrex Corporation
  • Rottendorf Pharma GmbH
  • Glatt GmbH
  • Hovione
  • Aphena Pharma Solutions
  • HERMES PHARMA GmbH
  • Lonza Group
  • Catalent

Key Segments Covered in Outsourced Clinical Trials & Formulation Industry Research

Outsourced Clinical Trials & Formulation Market by Product:

  • Oral dosage Forms
    • Solid dosage Forms
    • Liquid Dosage Forms
    • Semi-solid Dosage Forms
  • Injectable Dosage Forms
  • Others

Outsourced Clinical Trials & Formulation Market by Application:

  • API Manufacturing
  • Fill-Finish Product Manufacturing
  • Drug Product Development
  • Packaging / labeling
  • Others

Outsourced Clinical Trials & Formulation Market by End User:

  • Big Pharmaceutical /Biotech Companies
  • Small & Medium Size Pharma/Biotech Companies
  • Emerging/virtual Pharma Companies
  • Nutraceutical Companies

Outsourced Clinical Trials & Formulation Market by Region:

  • North America Outsourced Clinical Trials & Formulation Market
  • Latin America Outsourced Clinical Trials & Formulation Market
  • Europe Outsourced Clinical Trials & Formulation Market
  • South Asia Outsourced Clinical Trials & Formulation Market
  • East Asia Outsourced Clinical Trials & Formulation Market
  • Oceania Outsourced Clinical Trials & Formulation Market
  • Middle East & Africa Outsourced Clinical Trials & Formulation Market

Table of Contents

1. Executive Summary

  • 1.1. Global Outsourced Clinical Trials & Formulation Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Outsourced Clinical Trials & Formulation Market Outlook, 2018 - 2031

  • 3.1. Global Outsourced Clinical Trials & Formulation Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Oral dosage Forms
        • 3.1.1.1.1. Solid dosage Forms
        • 3.1.1.1.2. Liquid Dosage Forms
        • 3.1.1.1.3. Semi-solid Dosage Forms
      • 3.1.1.2. Injectable Dosage Forms
      • 3.1.1.3. Others
  • 3.2. Global Outsourced Clinical Trials & Formulation Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. API Manufacturing
      • 3.2.1.2. Fill-Finish Product Manufacturing
      • 3.2.1.3. Drug Product Development
      • 3.2.1.4. Packaging / labeling
      • 3.2.1.5. Others
  • 3.3. Global Outsourced Clinical Trials & Formulation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Big Pharmaceutical /Biotech Companies
      • 3.3.1.2. Small & Medium Size Pharma/Biotech Companies
      • 3.3.1.3. Emerging/virtual Pharma Companies
      • 3.3.1.4. Nutraceutical Companies
  • 3.4. Global Outsourced Clinical Trials & Formulation Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Outsourced Clinical Trials & Formulation Market Outlook, 2018 - 2031

  • 4.1. North America Outsourced Clinical Trials & Formulation Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Oral dosage Forms
        • 4.1.1.1.1. Solid dosage Forms
        • 4.1.1.1.2. Liquid Dosage Forms
        • 4.1.1.1.3. Semi-solid Dosage Forms
      • 4.1.1.2. Injectable Dosage Forms
      • 4.1.1.3. Others
  • 4.2. North America Outsourced Clinical Trials & Formulation Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. API Manufacturing
      • 4.2.1.2. Fill-Finish Product Manufacturing
      • 4.2.1.3. Drug Product Development
      • 4.2.1.4. Packaging / labeling
      • 4.2.1.5. Others
  • 4.3. North America Outsourced Clinical Trials & Formulation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Big Pharmaceutical /Biotech Companies
      • 4.3.1.2. Small & Medium Size Pharma/Biotech Companies
      • 4.3.1.3. Emerging/virtual Pharma Companies
      • 4.3.1.4. Nutraceutical Companies
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Outsourced Clinical Trials & Formulation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Outsourced Clinical Trials & Formulation Market Outlook, 2018 - 2031

  • 5.1. Europe Outsourced Clinical Trials & Formulation Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Oral dosage Forms
        • 5.1.1.1.1. Solid dosage Forms
        • 5.1.1.1.2. Liquid Dosage Forms
        • 5.1.1.1.3. Semi-solid Dosage Forms
      • 5.1.1.2. Injectable Dosage Forms
      • 5.1.1.3. Others
  • 5.2. Europe Outsourced Clinical Trials & Formulation Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. API Manufacturing
      • 5.2.1.2. Fill-Finish Product Manufacturing
      • 5.2.1.3. Drug Product Development
      • 5.2.1.4. Packaging / labeling
      • 5.2.1.5. Others
  • 5.3. Europe Outsourced Clinical Trials & Formulation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Big Pharmaceutical /Biotech Companies
      • 5.3.1.2. Small & Medium Size Pharma/Biotech Companies
      • 5.3.1.3. Emerging/virtual Pharma Companies
      • 5.3.1.4. Nutraceutical Companies
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Outsourced Clinical Trials & Formulation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Outsourced Clinical Trials & Formulation Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Outsourced Clinical Trials & Formulation Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Oral dosage Forms
        • 6.1.1.1.1. Solid dosage Forms
        • 6.1.1.1.2. Liquid Dosage Forms
        • 6.1.1.1.3. Semi-solid Dosage Forms
      • 6.1.1.2. Injectable Dosage Forms
      • 6.1.1.3. Others
  • 6.2. Asia Pacific Outsourced Clinical Trials & Formulation Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. API Manufacturing
      • 6.2.1.2. Fill-Finish Product Manufacturing
      • 6.2.1.3. Drug Product Development
      • 6.2.1.4. Packaging / labeling
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Outsourced Clinical Trials & Formulation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Big Pharmaceutical /Biotech Companies
      • 6.3.1.2. Small & Medium Size Pharma/Biotech Companies
      • 6.3.1.3. Emerging/virtual Pharma Companies
      • 6.3.1.4. Nutraceutical Companies
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Outsourced Clinical Trials & Formulation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Outsourced Clinical Trials & Formulation Market Outlook, 2018 - 2031

  • 7.1. Latin America Outsourced Clinical Trials & Formulation Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Oral dosage Forms
        • 7.1.1.1.1. Solid dosage Forms
        • 7.1.1.1.2. Liquid Dosage Forms
        • 7.1.1.1.3. Semi-solid Dosage Forms
      • 7.1.1.2. Injectable Dosage Forms
      • 7.1.1.3. Others
  • 7.2. Latin America Outsourced Clinical Trials & Formulation Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. API Manufacturing
      • 7.2.1.2. Fill-Finish Product Manufacturing
      • 7.2.1.3. Drug Product Development
      • 7.2.1.4. Packaging / labeling
      • 7.2.1.5. Others
  • 7.3. Latin America Outsourced Clinical Trials & Formulation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Big Pharmaceutical /Biotech Companies
      • 7.3.1.2. Small & Medium Size Pharma/Biotech Companies
      • 7.3.1.3. Emerging/virtual Pharma Companies
      • 7.3.1.4. Nutraceutical Companies
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Outsourced Clinical Trials & Formulation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Outsourced Clinical Trials & Formulation Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Outsourced Clinical Trials & Formulation Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Oral dosage Forms
        • 8.1.1.1.1. Solid dosage Forms
        • 8.1.1.1.2. Liquid Dosage Forms
        • 8.1.1.1.3. Semi-solid Dosage Forms
      • 8.1.1.2. Injectable Dosage Forms
      • 8.1.1.3. Others
  • 8.2. Middle East & Africa Outsourced Clinical Trials & Formulation Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. API Manufacturing
      • 8.2.1.2. Fill-Finish Product Manufacturing
      • 8.2.1.3. Drug Product Development
      • 8.2.1.4. Packaging / labeling
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Outsourced Clinical Trials & Formulation Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Big Pharmaceutical /Biotech Companies
      • 8.3.1.2. Small & Medium Size Pharma/Biotech Companies
      • 8.3.1.3. Emerging/virtual Pharma Companies
      • 8.3.1.4. Nutraceutical Companies
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Outsourced Clinical Trials & Formulation Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Outsourced Clinical Trials & Formulation Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Outsourced Clinical Trials & Formulation Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Outsourced Clinical Trials & Formulation Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc. (Patheon)
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Piramal Pharma Solutions
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. BioXcellence (Boehringer Ingelheim International GmbH)
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Siegfried Holding AG
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Evotec A.G.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Ascendia Pharmaceuticals
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Experic Services
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Quotient Sciences
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Velesco Pharmaceutical Services, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Elements Group (Avomeen)
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. VxP Pharma
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Adare Pharmaceuticals, Inc.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. KP Pharmaceutical Technology Inc.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Enteris Biopharma, Inc.
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!